UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000015392 |
|---|---|
| Receipt number | R000017756 |
| Scientific Title | Analysis of efficacy of contrast-enhanced ultrasonography with Sonazoid on treatment evaluation after local therapy for hepatocellular carcinoma (Comparison with transvenous contrast-enhanced computed tomography) |
| Date of disclosure of the study information | 2014/10/10 |
| Last modified on | 2014/10/09 19:21:48 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Analysis of efficacy of contrast-enhanced ultrasonography with Sonazoid on treatment evaluation after local therapy for hepatocellular carcinoma (Comparison with transvenous contrast-enhanced computed tomography)
Acronym
Efficacy of contrast-enhanced ultrasonography on treatment evaluation after local therapy for hepatocellular carcinoma
Scientific Title
Analysis of efficacy of contrast-enhanced ultrasonography with Sonazoid on treatment evaluation after local therapy for hepatocellular carcinoma (Comparison with transvenous contrast-enhanced computed tomography)
Scientific Title:Acronym
Efficacy of contrast-enhanced ultrasonography on treatment evaluation after local therapy for hepatocellular carcinoma
Region
| Japan |
Condition
Condition
Hepatocellular carcinoma
Classification by specialty
| Hepato-biliary-pancreatic medicine |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To evaluate the efficacy on treatment evaluation for hepatocellular carcinoma with hypervascular using contrast-enhanced ultrasonography
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
To evaluate the treatment evaluation for hepatocelluar carcinoma after local therapy using contrast-enhanced ultrasonography compared with contrast-enhanced computed tomography in six months after the treatment
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Diagnosis
Type of intervention
| Medicine |
Interventions/Control_1
Microbubble contrast agents; Sonazoid
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 80 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
1. Patients who were diagnosed as hepatocellular carcinoma with hypervascular using intravenous contrast-enhanced computed tomography
2. Patients who were planned to receive percutaneous radiofrequency ablation or percutaneous ethanol injection therapy (Hepatic arterial embolization is not exclusion criteria)
3. Patients who were planned to receive intravenous contrast-enhanced computed tomography for treatment evaluation
4. Having received adequate explanation of the contents of the trial and given their written consent
Key exclusion criteria
1. Egg allergy
2. Severe lung disease
3. Severe heart disease
4. Allergic to iodine
5. Difficult to follow up in our hospital
6. Determined to be ineligible by the physician in charge for any other reason
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Hitoshi Maruyama |
Organization
Chiba University Graduate School of Medicine
Division name
Department of Gastroenterology and Nephrology
Zip code
Address
1-8-1, Inohana, Chuou-ku, Chiba, Japan
TEL
043-226-2083
maru-cib@umin.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Hitoshi Maruyama |
Organization
Chiba University Graduate School of Medicine
Division name
Department of Gastroenterology and Nephrology
Zip code
Address
1-8-1, Inohana, Chuou-ku, Chiba, Japan
TEL
043-226-2083
Homepage URL
maru-cib@umin.ac.jp
Sponsor or person
Institute
Chiba University Graduate School of Medicine, Department of Gastroenterology and Nephrology
Institute
Department
Personal name
Funding Source
Organization
Chiba University Graduate School of Medicine, Department of Gastroenterology and Nephrology
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2014 | Year | 10 | Month | 10 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2008 | Year | 07 | Month | 23 | Day |
Date of IRB
Anticipated trial start date
| 2008 | Year | 08 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2014 | Year | 10 | Month | 09 | Day |
Last modified on
| 2014 | Year | 10 | Month | 09 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017756
